This inventor holds 8 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Oxthera Intellectual Property Ab, Captozyme, LLC, Oxidien Pharmaceuticals, LLC. Active years: 2013-2023.
Company Filing History:
6 out of 10 
1 out of 1 
1 out of 1 Years Active: 2013-2023
Title: The Innovations of Aaron Cowley
Introduction
Aaron Cowley is an accomplished inventor based in Gainesville, FL (US). He holds a total of 8 patents that reflect his significant contributions to the field of biotechnology, particularly in the area of oxalate degradation.
Latest Patents
Among his latest patents is the invention of high-efficiency oxalate-degrading enzymes for the degradation of both insoluble and soluble oxalate. This invention discloses oxalate-inducing enzymes that exhibit pH and thermal stability, along with methods for their application in food processing. Another notable patent involves secretagogues derived from Oxalobacter formigenes. This invention relates to a secretagogue compound derived from oxalate-degrading bacteria, aimed at treating oxalate-related diseases and imbalances. The administration of this secretagogue has been shown to reduce urinary and plasma oxalate levels in subjects.
Career Highlights
Throughout his career, Aaron Cowley has worked with notable companies such as Oxthera Intellectual Property AB and Captozyme, LLC. His work has significantly advanced the understanding and treatment of oxalate-related conditions.
Collaborations
Aaron has collaborated with esteemed colleagues, including Qingshan Li and Harmeet Sidhu, contributing to the innovative research in his field.
Conclusion
Aaron Cowley's work exemplifies the impact of innovation in biotechnology, particularly in addressing health issues related to oxalate. His patents and collaborations continue to pave the way for advancements in this important area of research.